Issue and repurchase of series C shares for performance-based share saving program

On March 22, 2022 Pursuant to the authorization granted by the annual general meeting on 1 June 2021, the board of directors of Alligator Bioscience AB ("Alligator") reported that it has resolved to issue and immediately thereafter repurchase 949,850 series C shares (Press release, Alligator Bioscience, MAR 22, 2022, View Source [SID1234610570]). The shares are issued and repurchased in accordance with the performance-based share saving program LTI 2021, which was adopted by the annual general meeting on 1 June 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pursuant to the authorization granted by the annual general meeting on 1 June 2021, the board of directors of Alligator has resolved on a directed issue of 949,850 series C shares to DNB Bank ASA, Sweden Branch ("DNB"). The subscription price per share amounts to SEK 0.40, which corresponds to the quota value of the shares. Furthermore, the board of directors has resolved to immediately repurchase all 949,850 series C shares from DNB at a price corresponding to the subscription price.

The purpose of the issue and the repurchase of series C shares is to, when the series C shares have been converted to ordinary shares, ensure delivery of matching shares and performance shares to employees of Alligator who are participating in the performance-based share saving program LTI 2021, which was adopted by the annual general meeting on 1 June 2021. Allotment of matching shares and performance shares in LTI 2021 shall take place within 60 days after 30 September 2024.

Since previously, Alligator holds no series C shares. The series C shares carry one-tenth of a vote per share and do not entitle to dividends.

This information was submitted for publication, through the agency of the contact person set out above, at 18:00 CET on 22 March 2022.